Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $20.84 $27.48 Friday, 10th May 2024 CORT stock ended at $27.04. This is 1.65% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.50% from a day low at $26.55 to a day high of $27.48.
90 days $20.84 $27.48
52 weeks $20.84 $34.28

Historical Corcept Therapeutics Incorporated prices

Date Open High Low Close Volume
Sep 16, 2016 $5.78 $5.80 $5.68 $5.76 1 074 000
Sep 15, 2016 $5.76 $5.80 $5.70 $5.75 258 000
Sep 14, 2016 $5.73 $5.85 $5.68 $5.75 222 200
Sep 13, 2016 $5.66 $5.75 $5.56 $5.74 198 300
Sep 12, 2016 $5.42 $5.75 $5.42 $5.75 223 100
Sep 09, 2016 $5.63 $5.69 $5.47 $5.48 160 400
Sep 08, 2016 $5.75 $5.75 $5.65 $5.70 150 800
Sep 07, 2016 $5.49 $5.73 $5.46 $5.71 263 400
Sep 06, 2016 $5.35 $5.50 $5.31 $5.48 207 800
Sep 02, 2016 $5.38 $5.41 $5.25 $5.31 101 100
Sep 01, 2016 $5.33 $5.45 $5.24 $5.35 134 000
Aug 31, 2016 $5.42 $5.42 $5.31 $5.33 266 800
Aug 30, 2016 $5.39 $5.49 $5.35 $5.41 226 400
Aug 29, 2016 $5.53 $5.53 $5.39 $5.40 129 100
Aug 26, 2016 $5.44 $5.55 $5.37 $5.50 117 800
Aug 25, 2016 $5.50 $5.65 $5.41 $5.45 131 800
Aug 24, 2016 $5.64 $5.82 $5.49 $5.50 217 000
Aug 23, 2016 $5.64 $5.75 $5.58 $5.64 247 300
Aug 22, 2016 $5.51 $5.66 $5.48 $5.65 276 900
Aug 19, 2016 $5.61 $5.63 $5.35 $5.53 322 100
Aug 18, 2016 $5.69 $5.76 $5.57 $5.62 250 100
Aug 17, 2016 $5.70 $5.79 $5.65 $5.69 182 600
Aug 16, 2016 $5.76 $5.77 $5.66 $5.69 182 600
Aug 15, 2016 $5.77 $5.90 $5.73 $5.81 343 700
Aug 12, 2016 $5.78 $5.85 $5.71 $5.77 122 000
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT